The University of Wisconsin–Madison is set to receive more than $56 million in new funding for research initiatives after the passage of two federal appropriations packages....
Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many side effects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease....
Moultrie explains that “people from marginalized populations must be fully welcome and treated equitably, sharing the same experience as earlier participants in all these discussions. This includes having updates on earlier conversations to enable full participation in current discussions....
Effective April 1, 2024, Dudley Lamming, PhD, associate professor, Endocrinology, Diabetes and Metabolism, will become the Department of Medicine’s next Vice Chair for Biomedical Research....
Kristi Schaeve is the Industry Liaison, Biohealth & Clinical Research for the Clinical Trials Institute....
Many patients are reluctant to undergo colonoscopies or conduct at-home fecal tests. Doctors see potential in another screening method....
Trustworthy & Responsible AI Network (TRAIN) will share best practices related to the safety, reliability and monitoring of AI algorithms, and the skill sets required to manage AI responsibly....
Surrounded by family, friends, colleagues, mentors and others, six remarkable women were celebrated on Thursday, March 7th for their unwavering dedication in their respective fields....
On Wednesday, undergraduate students from UW–Madison and campuses across the Universities of Wisconsin gathered at the Wisconsin State Capitol for the annual Research in the Rotunda event to present research findings to Wisconsin legislators, state leaders, UW alumni and members of the public....
According to the National Women’s History Alliance, this year Women’s History Month is honoring women who advocate for equity, diversity and inclusion, and few embody that theme more than Shiva Bidar-Sielaff....
